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1  Pazopanib plasma concentrations calculated with the use of dried 
blood spots are in good agreement with pazopanib concentrations 
measured in plasma. (this thesis) 
2  Midazolam exposure as a measure of cyp3a4 activity can explain  
a large percentage of the variability in sunitinib drug exposure 
between patients. (this thesis) 
3  In patients with gastrointestinal stromal tumors (gist), the influence 
of major gastrectomy on drug exposure should be taken into account 
when starting treatment with tyrosine kinase inhibitors. (this thesis) 
4  Dose reductions and everolimus induced stomatitis are strongly 
associated with systemic everolimus drug exposure in patients  
with cancer. (this thesis) 
5  Dose individualization should become a standard of care and  
a priority in research for new small molecules in development.  
(H.J. Klümpen et al. Cancer Treat Rev. 2011;37(4):251-260) 
6  In light of the variability and the relationship between  
systemic exposure and clinical benefit and toxicities in mRCC,  
dose adjustments based on trough plasma concentrations  
may provide a method to optimize therapy with pazopanib  
by maintaining therapeutically effective blood levels, while 
minimizing AEs whenever possible. (Suttle et al. Br J Cancer. 
2014;111(10):1909-1916) 
7  As we enter an era of targeted anticancer agents with a monthly  
cost measured in thousands of dollars, we should view drug-drug  
or drug-food interactions as opportunities to lower costs.  
(M. Ratain et al. J Clin Oncol. 2007;25(23):3397-3398) 
8  If it were not for the great variability among individuals,  
medicine might as well be a science, not an art. (Sir William Osler, 1892) 
9  With self-discipline, all things are possible. (Theodore Roosevelt,1858) 
10  Lose your dreams and you might lose your mind.  
(Ruby Tuesday, Rolling Stones) 
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